These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17588786)

  • 21. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Apostolakis S; Shantsila E; Lip GY; Lane DA
    Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
    [No Abstract]   [Full Text] [Related]  

  • 23. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
    Markus HS; Droste DW; Kaps M; Larrue V; Lees KR; Siebler M; Ringelstein EB
    Circulation; 2005 May; 111(17):2233-40. PubMed ID: 15851601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy.
    Rosenbaum A; Rizvi AZ; Alden PB; Tretinyak AS; Graber JN; Goldman JA; Sullivan TM
    Ann Vasc Surg; 2011 Jan; 25(1):25-31. PubMed ID: 20889291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.
    Alcocer F; Novak Z; Combs BR; Lowman B; Passman MA; Mujib M; Jordan WD
    J Vasc Surg; 2014 Apr; 59(4):950-5. PubMed ID: 24491238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes associated with combined antiplatelet and anticoagulant therapy.
    Johnson SG; Rogers K; Delate T; Witt DM
    Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Healey JS
    Thromb Haemost; 2009 Nov; 102(5):912-3. PubMed ID: 19888528
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of 'on-treatment platelet reactivity' and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
    Kinsella JA; Oliver Tobin W; Tierney S; Feeley TM; Egan B; Coughlan T; Ronan Collins D; O'Neill D; Harbison JA; Doherty CP; Madhavan P; Moore DJ; O'Neill SM; Colgan MP; Saqqur M; Murphy RP; Moran N; Hamilton G; McCabe DJH
    J Neurol Sci; 2017 May; 376():133-139. PubMed ID: 28431600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
    Furlan AJ
    Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of transcranial Doppler embolic monitoring in the management of intracranial arterial stenosis.
    Sebastian J; Derksen C; Khan K; Saqqur M
    J Neuroimaging; 2011 Apr; 21(2):e166-8. PubMed ID: 20002966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
    Liao JK
    Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of dual antiplatelet therapy in cerebrovascular disease as demonstrated by a decline in microembolic signals. A report of eight cases.
    Esagunde RU; Wong KS; Lee MP; Gan HY; Wong MC; Chang HM; Chen CL
    Cerebrovasc Dis; 2006; 21(4):242-6. PubMed ID: 16446537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to Antiplatelet Therapy Is Associated With Symptoms of Cerebral Ischemia in Carotid Artery Disease.
    Ball STE; Taylor R; McCollum CN
    Vasc Endovascular Surg; 2020 Nov; 54(8):712-717. PubMed ID: 32856558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Counting the true cost of antiplatelet therapy for stroke prevention.
    Morton JA; Newton J; Gray CS
    Age Ageing; 2005 May; 34(3):212-4. PubMed ID: 15863405
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiplatelet agents for stroke prevention following transient ischemic attack.
    Weinberger J
    South Med J; 2008 Jan; 101(1):70-8. PubMed ID: 18176296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticoagulant, antiplatelet agents].
    Ishikawa K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():647-53. PubMed ID: 12735045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.